| PE18.02 | Predicting PrEP efficacy in women with partial adherence to tenofovir disoproxil fumarate/emtricitabine | E-poster | Mathematical modelling: impact and effectiveness |
| PE19.01 | Population-level correlation between incidence of selected sexually transmitted infections and HIV-1 among women participating in HIV pre-exposure prophylaxis trials in Africa | E-poster | Microbiome & STI: impact on prevention |
| PE19.02 | Immunomodulatory properties of cervicovaginal Lactobacillus isolates are associated with lactic acid production and bacterial proteome profiles | E-poster | Microbiome & STI: impact on prevention |
| PE19.03 | Lactic acid produced by an optimal vaginal microbiota promotes cervicovaginal epithelial barrier integrity: implications for HIV transmission | E-poster | Microbiome & STI: impact on prevention |
| PE19.04 | Correlates of STI acquisition during the first years after sexual initiation: a longitudinal cohort study of sexually inexperienced adolescent girls and young women in Kenya | E-poster | Microbiome & STI: impact on prevention |
| PE19.05 | Cervicovaginal microbiota affects the human ectocervical epithelial barrier as determined by in situ image analysis and protein profiling | E-poster | Microbiome & STI: impact on prevention |
| PE19.06 | Female genital tract secretions obtained in the setting of bacterial vaginosis enhance HIV infection | E-poster | Microbiome & STI: impact on prevention |
| PE19.07 | HIV exposure alters the fecal microbiome in Nigerian infants | E-poster | Microbiome & STI: impact on prevention |
| PE19.08 | Gardnerella subgroups exhibit divergent associations with cervicovaginal cytokines in a longitudinal cohort of Kenyan women: Implications for HIV susceptibility | E-poster | Microbiome & STI: impact on prevention |
| PE19.09LB | Experimental microbial dysbiosis enhances rectal SIV acquisition in male rhesus macaques | E-poster | Microbiome & STI: impact on prevention |